stockrowIDEXX Laboratories, Inc.
IDXX Healthcare Diagnostics & Research
IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +9.86%
- EPS
- +17.3%
- Free cash flow
- +17.6%
- Total debt
- −28.6%
Quarter to September 2026, against a year earlier
Follow IDXX
Alert me
IDEXX Laboratories, Inc. (IDXX) Free cash flow
IDEXX Laboratories, Inc.'s free cash flow for fiscal 2025 was $1.0B, up 30.8% from $798.1M in fiscal 2024. Over the twelve months to 30 September 2026 it was $1.3B. Over the past ten years it has ranged from $138.9M (fiscal 2015) to $1.0B (fiscal 2025) — the current reading is the highest in ten years. Free cash flow has risen for 3 consecutive fiscal years. IDEXX Laboratories, Inc. ranks 5th of 49 Diagnostics & Research companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $1.0B | 30.76% |
| FY2024 | $798.1M | 3.26% |
| FY2023 | $772.9M | 101.19% |
| FY2022 | $384.1M | (39.60%) |
| FY2021 | $636.0M | 17.68% |
| FY2020 | $540.4M | 77.81% |
| FY2019 | $303.9M | 9.66% |
| FY2018 | $277.1M | (6.55%) |
| FY2017 | $296.6M | 8.18% |
| FY2016 | $274.2M | 97.40% |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $420.8M | 31.24% |
| Jun 2026 | $320.6M | 37.92% |
| Mar 2026 | $232.5M | (28.72%) |
| Dec 2025 | $326.1M | (8.87%) |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| IQV IQVIA Holdings Inc. compare | $2.1B |
| DGX Quest Diagnostics Incorporated compare | $1.4B |
| IDXX IDEXX Laboratories, Inc. | $1.3B |
| LH Labcorp Holdings Inc. compare | $1.3B |
| A Agilent Technologies, Inc. compare | $1.3B |
| ILMN Illumina, Inc. compare | $1.1B |
| MTD Mettler-Toledo International, Inc. compare | $984.4M |
| WAT Waters Corporation compare | $258.4M |
| NTRA Natera, Inc. compare | $52.5M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on IDXX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement